| Page | ||||
|---|---|---|---|---|
| Reference | and administrative | information | ||
| Chairman's | Letter | |||
| Trustees' | Report | 3 —12 | ||
| Independent Auditor's |
Report | 13-16 | ||
| Statement | of Financial | Activities | 17 | |
| Balance Sheet | 18 | |||
| Statement | of Cash Flows | 19 | ||
| Notes to the Financial | Statements | 20- 34 |
| CHARITY NAME | Prostate Cancer | Prostate Cancer | Research | Research | Research | |
|---|---|---|---|---|---|---|
| CHARITY REGISTRATION NUMBER | 1156027 | |||||
| REGISTERED OFFICE | Suite 2 | |||||
| 23-24 Great James Street | ||||||
| London | ||||||
| WC1N 3ES | ||||||
| PRINCIPAL OFFICE | Suite 2 | |||||
| 23-24 Great James Street | ||||||
| London | ||||||
| WC1N 3ES | ||||||
| TRUSTEES | Matthew Ellis, |
Chair of Trustees | ||||
| Michele Hunter | (resigned | 11 July 2022) | ||||
| Shaun Grady | ||||||
| Ben Monro-Davies | ||||||
| Mark Clark | ||||||
| Suman Shirodkar | MBBS, | PHD | ||||
| Richard Collier | ||||||
| Jonathan Badger |
||||||
| Ameet Gill OBE |
||||||
| Trevor Back | ||||||
| Marcella Turner | ||||||
| Louisa Fleur (appointed | 7 | March 2023) | ||||
| EXECUTIVE DIRECTOR | Oliver Kemp | |||||
| HONORARY TREASURER | Ceri Evans | |||||
| BANKERS | Lloyds TSB | |||||
| Oxford Street | ||||||
| London | ||||||
| BX1 1LT | ||||||
| HSBC | ||||||
| 39Tottenham | Court Road | |||||
| London | ||||||
| W1T 2AR | ||||||
| Barclays Bank | pic | |||||
| London Bridge | Branch | |||||
| 29 Borough High Street |
||||||
| London | ||||||
| SE1 1LY | ||||||
| AUDITOR | Crowe U.K. LLP | |||||
| Aquis House | ||||||
| 49-51 Blagrave | Street | |||||
| Reading | ||||||
| RG1 1PL |
| Total | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Notes | Unrestricted | Restricted | funds | funds | |||||
| funds | funds | 2023 | 2022 | ||||||
| Income and endowments | from: | ||||||||
| Donations and |
legacies | 1,822,685 | 1,164,925 | 2,987,610 | 2,660,859 | ||||
| Investments | 13,336 | 13,336 | 14,962 | ||||||
| Other income | 1 854 | 1 854 | |||||||
| Total income | ~B3Z,BZ5 | ~~~ | '+Q~QQ | 2675821 | |||||
| Expenditure on: |
|||||||||
| Raising funds | 5 | 1,049,831 | 1,049,831 | 879,060 | |||||
| Charitable activities |
6 | 1 554435 | 850547 | 2404 982 | 1 743661 | ||||
| Total expenditure | ~Q~ | ~5L54Z | ~4j~ | 2622 721 | |||||
| Net movement | in funds | ~788391 | 314378 | ~452013 | 53 100 | ||||
| Transfer of funds | 107,887 | (107,887) | |||||||
| Fund balances | brought | forward | at | ||||||
| 31 March 2022 | 3066436 | 107667 | 3 176325 | 3 123225 | |||||
| Fund balances carried at 31 March 2023 |
forward | ~4QL934 | '~ZB | ~2~ | 3 176325 |
| Notes | 2023 | 2022f | ||||
|---|---|---|---|---|---|---|
| FIXEDASSETS | ||||||
| Property and equipment |
10 | 922,525 | 943,021 | |||
| Fixed term deposits | ||||||
| 922,525 | 943,021 | |||||
| CURRENT ASSETS | ||||||
| Debtors | 11 | 976,313 | 452,574 | |||
| Fixed term deposits Cash at bank and in hand |
12 | 1610178 | 515,000 1653379 |
|||
| 2,586,491 | 2,620,953 | |||||
| CREDITORS: Amounts | due within one year | 13 | ~784704 | ~367649 | ||
| NET CURRENT ASSETS | 1 801 787 | 2251 177 | ||||
| CREDITORS: Amounts | due after one year | |||||
| NET ASSETS | ~~312 | 3 176325 | ||||
| FUNDS OF THE | CHARITY | |||||
| RESTRICTED | 314,378 | 107,887 | ||||
| UNRESTRICTED | ||||||
| Designated funds |
||||||
| Property | 922,525 | 943,021 | ||||
| Support and | working | capital | 119,361 | 116,924 | ||
| Grants | 1,167,545 | 1,664,729 | ||||
| General funds | 200 503 | 343 764 | ||||
| TOTAL FUNDS | 15 | ~2~ | 3 176325 |
| 2023 | 2022 | ||||||
|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: |
|||||||
| Net cash provided by operating activities |
(4) | ~571537) | ~38244 | ||||
| Cash flows from investing activities: |
|||||||
| Dividends, interest and rents from investments |
13,336 | 14,962 | |||||
| Proceeds from sale of investments Management fees for short term deposits |
1,975 ~1975) |
1,931 ~1931 |
|||||
| Net cash from investing activities |
13336 | 14962 | |||||
| Change in cash and cash equivalents |
in the | reporting | period | ~558201) | 21282 | ||
| Cash and cash equivalents at the beginning |
of | the reporting | |||||
| period | 2168379 | 2 189661 | |||||
| Cash and cash equivalents at the end |
ofthe | reporting | period | ~~8 | 2 168379 | ||
| Where cash and cash equivalents consists |
of: | ||||||
| Cash at bank and in hand |
12 | 823,536 | 1,045,808 | ||||
| Fixed term deposits (current and non-current) |
786 642 | 1 122571 | |||||
| Cash and cash equivalents | ~1QJ28 | 2 168 379 | |||||
| (a) Reconciliation of net expenditure to net |
cash | flows from | operating | activities | |||
| Net income for the reporting period |
(452,013) | 53,100 | |||||
| Adjustment for: |
|||||||
| Depreciation charge |
20,496 | 20,496 | |||||
| Dividends and interest from investments |
(13,336) | (14,962) | |||||
| (Increase)/ Decrease in debtors |
(523,739) | (100,384) | |||||
| Increase/(Decrease) in creditors |
397055 | 5506 | |||||
| Net cash provided by/ (used in) by operating |
activities | 36244 |
| nations | an | d Legacies | —Current year | |||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | ||||
| Funds | Funds | 2023 | ||||
| Donations, | fundraising | and | P | |||
| legacies | ||||||
| Committed | giving | 1,082,077 | 1,164,925 | 2,247,002 | ||
| Legacies | and bequests | 740 608 | 740 608 | |||
| nations | and Legacies | —Comparative | ||||
| Unrestricted | Restricted | Total | ||||
| Donations, | fundraising | and legacies | Funds | Funds | 2022f | |
| Committed | giving | 1,644,843 | 468,125 | 2,112,968 | ||
| Legacies | and bequests | 547891 | 547891 | |||
| 2 192734 | 468 125 | 2660859 |
| ome from investments | —Current year | |||
|---|---|---|---|---|
| Unrestricted | Restricted | Total | ||
| Funds | Funds | 2023 | ||
| Interest on cash deposits | 13336 | 13336 | ||
| ome from investments | —Comparative | |||
| Unrestricted | Restricted | Total | ||
| Funds | Funds | 2022 | ||
| interest on cash deposits | 14962 | 14962 | ||
| 14962 | 14962 |
| Unrestricted | Restricted | Total | |||
|---|---|---|---|---|---|
| Funds | Funds | 2023 | |||
| Fundraising | costs | 446,146 | 446,146 | ||
| Employment | costs | (see note 9) | 603 685 | 603685 | |
| penditure on raising funds —Comparative |
|||||
| Unrestricted | Restricted | Total | |||
| Funds | Funds | 2022 | |||
| Fundraising | costs | 435,770 | 435,770 | ||
| Employment | costs | (see note 9) | 443290 | 443290 | |
| aritable activities |
—Current year | ||||
| Unrestricted | Restricted | Total | |||
| Funds | Funds | 2023 | |||
| Grant funding | of activities (see note 8) | 622,851 | 850,547 | 1,473,398 | |
| Employment | costs | (see note 9) | 536,609 | 536,609 | |
| Project Management/EPPC | 157,137 | 157,137 | |||
| Support costs (see | note 7) | 237838 | 237838 | ||
| Total expenditure | on charitable | ||||
| activities |
| haritable activities —Comparative |
|||
|---|---|---|---|
| Unrestricted | Restricted | Total | |
| Funds | Funds | 2022 | |
| Grant funding ofactivities (see note 8) |
797,918 | 360,238 | 1,158,156 |
| Employment costs (see note 9) |
394,036 | 394,036 | |
| Project Management7'EPPC | 18,796 | 18,796 | |
| Support costs (see note 7) | 172673 | 172673 | |
| Total expenditure on charitable |
|||
| activities | 1363423 | 360238 | 1 743661 |
| Support costs are allocated on | Support costs are allocated on | the basis | of staff | of staff | of staff | time and | time and | comprising the following: |
comprising the following: |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2022 | |||||||||
| Other stationery and postage |
10,666 | 2,576 | ||||||||
| Communication expenses |
50,936 | 32,179 | ||||||||
| Booklets | 20,374 | 11,681 | ||||||||
| Office rent | 17,371 | 6,146 | ||||||||
| IT, phone and internet costs | 48,006 | 39,199 | ||||||||
| Recruitment | 741 | 711 | ||||||||
| Bank charges | 4,277 | 4,417 | ||||||||
| Memberships | 15,527 | 9,276 | ||||||||
| Sundry and office maintenance | 12,056 | 11,288 | ||||||||
| Depreciation | 20,496 | 20,496 | ||||||||
| Governance costs |
||||||||||
| Auditor's remuneration: |
||||||||||
| current year | 19,988 | 14,874 | ||||||||
| Trustee meeting expenses | ||||||||||
| Legal and professional | fees | 17400 | 18830 | |||||||
| Total | 172673 | |||||||||
| Grant funding activities |
||||||||||
| Name of institution | Research | Grants | Total | Total | ||||||
| 2023 | 2022f | |||||||||
| King's College London | Immunotherapy | 4,292 | 137,342 | |||||||
| PlexinB1 | 126,858 | 133,871 | ||||||||
| Wnt Signalling | 79,570 | |||||||||
| Cardiff University | Bone mets/Targeting | Wnt | ||||||||
| Signalling | 148,432 | 52,397 | ||||||||
| Cambridge University |
PTEN and | TSGs | 144,117 | 86,431 | ||||||
| ProCASP | 47,935 | 48,784 | ||||||||
| Aberdeen University |
SoloMERS | 98,169 | 121,984 | |||||||
| Francis Crick institute | Machine | learning | models | 51,220 | 39,808 | |||||
| Oxford University | 177Lu-PSMA | 117,012 | 113,232 | |||||||
| Newcastle University |
AR-V Splicing | 77,582 | 111,523 | |||||||
| Glycan drugs | targeting | bone | 134,179 | 43,880 | ||||||
| metastasis | ||||||||||
| University of East Anglia |
Al/Mathematical | Classification | 115,699 | 69,912 | ||||||
| UCL | STAMPEDE | 90,921 | 12,152 | |||||||
| Cancer Research UK |
Targeting | MCL-1 | 52,350 | 22,183 | ||||||
| Imperial College London | Obesity and Prostate | Cancer | 145,882 | 33,743 | ||||||
| University of Sunderland |
Disparities/Barriers | to | early | 31,056 | ||||||
| diagnosis | ||||||||||
| University of Essex |
Disparities/AR | risk | 21,683 | |||||||
| Other Grants costs | Research | grants | 66011 | 51344 | ||||||
| ~~66 | 1 158 158 |
| 2023 | 2022 | |||||
|---|---|---|---|---|---|---|
| Charitable | activities | 10 | ||||
| Fundraising | and marketing | 14 | ||||
| Total | 17 | |||||
| The aggregate | payroll costs ofthese persons were as follows: | |||||
| 2023 | 2022 | |||||
| Salaries | and | wages | 972,355 | 729,949 | ||
| Pensions | 34,392 | 25,474 | ||||
| National | Insurance | 105,058 | 67,607 | |||
| Training | and | recruitment | 28489 | 14296 | ||
| Total | ~L4L2R4 | 637326 | ||||
| The number | of employees | whose salary exceeded F60,000was: | ||||
| 2023 | 2022 | |||||
| No. | No. |
| Debtors | |||
|---|---|---|---|
| Debtors due within one | year | ||
| 2023 | 2022 | ||
| Donations Receivable |
|||
| Other debtors | 515,868 | 251,852 | |
| Amount due from related |
entity | 317,192 | 140,508 |
| Prepayments | 98625 | 56544 | |
| ~~88 | 449204 |
| Debtors more than one year | |||
|---|---|---|---|
| 2023 | 2022 | ||
| Prepayments | ~28 | 3370 | |
| 12. | Cash and cash equivalents | ||
| 2023 | 2022 | ||
| Cash | 823,536 | 1,045,808 | |
| Fixed term deposits | 786 642 ~~8 |
607571 1653379 |
| reditors | —amounts falling due within one y |
ear | |
|---|---|---|---|
| 2023 | 2022 | ||
| Creditors | Control Account | 143,453 | 103,700 |
| Accruals | 472,287 | 241,716 | |
| Deferred | Income | 158,676 | 34,041 |
| Other creditors | 10288 | 8 192 | |
| ~84+I | 387649 |
| t 31 March 2023 | the charity had received donatio |
ns specifically for future funding e |
vents. |
|---|---|---|---|
| 2023 | 2022 | ||
| Balance brought Movement in the |
forward year |
34,041 124835 |
104,804 ~70 763 |
| At 31 March 2023 | 34041 |
| Net (debt)/cash | - | current | year | |||
|---|---|---|---|---|---|---|
| At 1 April | Cash flow | At 31 March | ||||
| 2022 | 2023 | |||||
| Cash at bank and | in hand | 1,045,808 | (222,272) | 823,536 | ||
| Fixed term deposits | included | in cash equivalents | 607,571 | 179,071 | 786,642 | |
| Fixed term deposits Fixed term current |
(current | 8 fixed assets) | 515000 | ~515000) | ||
| Net (debt)/cash | 2 168379 | ~558 201) | ~1QJ28 | |||
| Net (debt)/cash | -comparative | |||||
| At 1 April | Cash flow | At31March | ||||
| 2021 | 2022 | |||||
| Cash at bank and | in hand | 1,343,434 | (297,626) | 1,045,808 | ||
| Fixed term deposits | included | in cash equivalents | 251,227 | 356,344 | 607,571 | |
| Fixed term deposits | (current | & fixed assets) | 260,000 | (260,000) | ||
| Fixed term current | 335000 | 180000 | 515000 | |||
| Net (debt)7'cash | 2 189661 | ~21282 | 2 168379 |
| nalysis of net assets between f | unds —current year | ||
|---|---|---|---|
| Unrestricted | Restricted | Total | |
| funds | |||
| Fixed assets | 922,525 | 922,525 | |
| Fixed term Investments | |||
| Debtors | 976,313 | 976,313 | |
| Cash and cash equivalents | 1,295,800 | 314,378 | 1,610,178 |
| Creditors | ~784704 | ~784 704 | |
| Net assets at the end of year | ~LGL934 | '~zB | ~2K~ |
| nalysis of net assets between f | unds —comparative | ||
|---|---|---|---|
| Unrestricted | Restricted | Total | |
| funds | |||
| Fixed assets | 943,021 | 943,021 | |
| Fixed term Investments | 515,000 | 515,000 | |
| Debtors | 452,574 | 452,574 | |
| Cash and cash equivalents Creditors |
1,545,492 ~387649 |
107,887 | 1,653,379 ~387649 |
| Net assets at the end of year | 3068438 | 107887 | 3176325 |
| '0 C ~C 0)O- Ql CL |
a$ 0 | Ql Ql |
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ql | N | |||||||||||||||||||||||
| Ql .= | N | 0 | ||||||||||||||||||||||
| cd | cd ~ | |||||||||||||||||||||||
| CD | ||||||||||||||||||||||||
| O | (d Ql |
a$ | ||||||||||||||||||||||
| V c ~ |
CV | 4l | (A (0 C) Ccl |
COw 'ct (0 (O (9 t Cll COr ~ w 1 |
CA CV (A N CCl Cb |
1 Cb CV CCI |
ct Cll Ol CI CV |
Ql 0 0 |
cl | cn Ql Q O cd CL 0 X Ql |
0) cdC 0& N0) 0 |
0) (d 0 Ql |
||||||||||||
| (h e (h (4 |
Ccl | (O O |
CV (O Cb |
'ct CV |
CA (O 00 ($) |
CO QO 1 |
CO CO Cl 1 |
&z C Ql ' Ql 0 (n ~ |
Ql cd cd 0 (n Ql~ 8 C cd~ (n .~ |
C U) C 0) |
QlO0) Ql E0 O |
|||||||||||||
| CV z o Z LLI eu o&z & LLI o I- gJ CO |
L- 'D Ql (h 4$$—4I 0 L 4l 'D 8 O. LLI |
Ol C) |
00 ($$ t ct |
' | cO ($$ct O CV |
(O(0 CV (0 CV |
Vl cd 0$ Ql 0 0 |
Ql a$ M (n 0$ 8 Q 0$ C K cd~ 0) Ql 0)~ cd ~ a$ O E (n8 Q) '~ O a$ 0~C cd |
Ql h~ P 8 QlC (d~ O cn N & 0$ Ql 0) Ql a$ 0)0 V) 0$ 0 |
OC Vl0) E0 0) cd E C 0) 0) V) (($ Vl cd |
0) OC Ul (D (D 0 a$ Ql 0) 1D Ql |
|||||||||||||
| Ql | (nC0 | Ql N0 8 0 |
U) | 0) O (D |
||||||||||||||||||||
| moO oz~ zc~ czz OL-~K z LLI u)Om OI-Z K 0 I- 0. LLII- z ~ |
Q. ~ |
cq Cl Cq Ql 0V |
(A 00 1 |
I | I | I | Ql Ql'p cd cd Ql Ql Ql a$ cd Vl (0 0$ QlO cd |
1 C 0 cd E 'c 0 Ql (n O (n |
0$ (D 0 0) 0 0 8 K 0) cdC (D0 (n 0& a$ 1D cd ~ |
0) Ql CL l a$~ 0~ Ql N (n cd c cd C Ql Ql (d0» N ~ N (D N 0« cd 0)N+ (n 2 ~ 8 (($ o Vl Ql .~ 0) & O Ql s 8 0 8 O» Vl |
C 0) 0 0) (n 0) C0 NC0 OC N CD 0) N0 CL E N 0$ |
0) E0 O (D O i V) 0& 0) CL N 0) 0 cd U Ql N 'p cd |
||||||||||||
| 8 C 4l O I N 'O C LL |
N 'O C Ll 'ZJ V Ql C D |
a$ 8 6 |
(II 'Dc Ll Ql (4 Ul O |
N ~ G |
cd CL cdO 0) C 0 cd 0 CL CL CD |
CL 0 s Cl |
cn 0) O N Ql a$0 I— |
N 'D C LL V (h8 II |
cn C 0 I— |
N C v Ql cd «5 CI |
0 Qlg cn cd Ql Ul Vl C N C8 Vl Ql h.8 V) ~ G |
0) (n Ql cd & 0.8 O— cd Ql 0 cn QlN cd Ql 0 8 0. W CD I—CL |
(n Ql + cn c Q (D cd ~ a- s C 0&0 Q) C 0~ 0) 8 C .CCC '0 0 a cd» (d cd M 8 0 C~'O 0) Ql C8 (n cd 0 cd Ql C (n g 8 (d 8~ CD 0 & |
(h~ C LL 'D 4l (h Ql K |
0C0 0) Ql 0) 0) (n 1D ~ CD O Vl 0) K |
i0 (D 1 a$O V) Ql O (n (D ~ 0 Ql |
~ 0) Vl C O. QlX |
| Total | |||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | funds | |||
| funds | funds | 2022 | |||
| Income and endowments | from: | ||||
| Donations and |
legacies | 2,192,734 | 468,125 | 2,660,859 | |
| Investments | 14,962 | 14,962 | |||
| Other income | |||||
| Total income | 2207666 | 468 125 | 2675821 | ||
| Expenditure on: |
|||||
| Raising funds | 879,060 | 879,060 | |||
| Charitable activities |
1383423 | 360238 | 1 743661 | ||
| Total expenditure | 2262483 | 360238 | 2622 721 | ||
| Net movement | in funds | ~54 787 | 107887 | 53 100 | |
| Transfer offunds | 16,110 | (16,110) | |||
| Fund balances | brought | forward at | |||
| 31March 2021 | 3 107115 | 16 110 | ~~12 ~22 | ||
| Fund balances | carried forward | ||||
| at31March 2022 | 3068438 | 107887 | 3176325 |